Biosenta Inc (TSE:ZRO)
:ZRO
Want to see TSE:ZRO full AI Analyst Report?
ZRO Stock Chart & Stats
C$0.08
-C$0.03(-11.36%)
At close: 4:00 PM EST
C$0.08
-C$0.03(-11.36%)
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.17
Previous CloseN/A
Volume1.00K
Average Volume (3M)2.93K
Market Cap
C$1.56M
Enterprise ValueC$2.94M
Total Cash (Recent Filing)C$10.38K
Total Debt (Recent Filing)C$973.87K
Price to Earnings (P/E)―
Beta2.27
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding34,768,887
10 Day Avg. Volume5,790
30 Day Avg. Volume2,930
Financial Highlights & Ratios
PEG Ratio0.59
Price to Book (P/B)-0.40
Price to Sales (P/S)3296.23
P/FCF Ratio-8.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Top-line MomentumA material increase in trailing-twelve-month revenue signals growing market traction and customer adoption of products. Sustained top-line momentum over multiple quarters can enable scale advantages, improve leverage on fixed costs, and provide a runway to push toward break-even if managed consistently.
Essential Product FocusThe company’s core product set targets structural needs—cleaning, disinfection and mold remediation—across residential, commercial and industrial end markets. These are recurring, regulatory- and health-driven demand areas that support a durable addressable market and licensing or channel expansion opportunities.
Improving Cash Burn TrendA meaningful reduction in free cash flow burn year-over-year reflects progress on cost controls or revenue mix improvements. Continued improvement in cash conversion is a durable sign management can extend runway and reduce reliance on dilutive financing if the trend persists across upcoming reporting periods.
Bears Say
Negative Shareholders' EquityA deeply negative equity base is a persistent solvency red flag that constrains financial flexibility. It increases the likelihood of dilution or distressed financings, weakens lender confidence, and limits the firm’s ability to absorb further losses or invest in growth without external recapitalization.
Persistent Cash OutflowsOngoing negative operating and free cash flow means the business is structurally consuming cash to sustain operations. This persistent cash burn necessitates continual external funding, restricting long-term planning, strategic investment and increasing refinancing and dilution risk for shareholders.
Unprofitable Core OperationsNegative gross margins indicate the company’s core products currently do not cover direct production costs, a structural issue for profitability. Without sustained margin recovery through pricing, cost reduction, or product mix shifts, achieving operating profitability will remain unlikely over the medium term.
Biosenta Inc News
ZRO FAQ
What was Biosenta Inc’s price range in the past 12 months?
Biosenta Inc lowest stock price was C$0.04 and its highest was C$0.17 in the past 12 months.
What is Biosenta Inc’s market cap?
Biosenta Inc’s market cap is C$1.56M.
When is Biosenta Inc’s upcoming earnings report date?
Biosenta Inc’s upcoming earnings report date is Sep 02, 2026 which is in 80 days.
How were Biosenta Inc’s earnings last quarter?
Biosenta Inc released its earnings results on May 29, 2026. The company reported -C$0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.016.
Is Biosenta Inc overvalued?
According to Wall Street analysts Biosenta Inc’s price is currently Overvalued.
Does Biosenta Inc pay dividends?
Biosenta Inc does not currently pay dividends.
What is Biosenta Inc’s EPS estimate?
Biosenta Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biosenta Inc have?
Biosenta Inc has 34,768,887 shares outstanding.
What happened to Biosenta Inc’s price movement after its last earnings report?
Biosenta Inc reported an EPS of -C$0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Biosenta Inc?
Currently, no hedge funds are holding shares in TSE:ZRO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Biosenta Inc
Biosenta Inc., a Toronto-based Canadian firm established in 1986, specializes in the development, manufacturing, and sale of antimicrobial chemical compounds for both residential and commercial applications throughout the country. The company is actively working on "true," an innovative, dual-action disinfectant with potent antimicrobial capabilities, engineered to instantaneously eradicate viruses, bacteria, mold, and various germs upon contact. Additionally, Biosenta Inc. intends to produce and distribute "Tri-Filler," an antimicrobial additive designed for bulking and filling purposes.
Technical Analysis
BioNeutra Global
―
Lifeist Wellness
―
Psyched Wellness
―
Happy Supplements Inc.
―
Pure to Pure Beauty Inc.
―